Ligand Partner TG Therapeutics Presents Positive Pre-clinical Data on IRAK4 Compounds at the American Association for Cancer Research (AACR) Annual Meeting April 20, 2015
Ligand Partner GlaxoSmithKline Announces EU Regulatory Submission Seeking Additional Indication for RevoladeĀ® February 6, 2015
Ligand to Present at BIO CEO and RBC Capital Markets Global Healthcare Conferences in February January 28, 2015
Ligand Partner Melinta Therapeutics Reports Positive Phase 3 Results for Captisol-enabled⢠Delafloxacin IV January 8, 2015